- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 319/04 - Dioxanes-1, 3Dioxanes-1, 3 hydrogénés
Détention brevets de la classe C07D 319/04
Brevets de cette classe: 34
Historique des publications depuis 10 ans
|
0
|
2
|
3
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| International Business Machines Corporation | 61471 |
2 |
| Merck Patent GmbH | 5768 |
2 |
| Sumitomo Chemical Company, Limited | 9047 |
2 |
| The General Hospital Corporation | 4771 |
2 |
| Takeda Pharmaceutical Company Limited | 2706 |
2 |
| Rhodia Operations | 1587 |
2 |
| BASF SE | 20991 |
1 |
| Centre National de La Recherche Scientifique | 10531 |
1 |
| Dow Global Technologies Inc. | 809 |
1 |
| The Regents of the University of Michigan | 4746 |
1 |
| Northwestern University | 3417 |
1 |
| A.P. Pharma, Inc. | 3 |
1 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
1 |
| BioLab Ltd. | 5 |
1 |
| Central Glass Company, Limited | 1271 |
1 |
| Emcure Pharmaceuticals Limited | 69 |
1 |
| Fukushima Medical University | 41 |
1 |
| IBM United Kingdom Limited | 4313 |
1 |
| JNC Corporation | 1563 |
1 |
| JNC Petrochemical Corporation | 400 |
1 |
| Autres propriétaires | 8 |